September 5, 2024Open Access

Patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer patients in Brazil receiving palbociclib

Key Points

Key points are not available for this paper at this time.

Abstract

To outline the demographic and clinical features, treatment approaches and clinical outcomes of patients treated with palbociclib as the initial therapy for HR+/HER2- advanced or metastatic breast cancer (aBC/mBC) in private healthcare facilities in Brazil.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Cite this study

Simon et al. (Thu,) studied this question.

www.synapsesocial.com/papers/68e59453b6db64358752fbe9 — DOI: https://doi.org/10.1080/14796694.2024.2388022

Authors

Patricia Simon

Ankita Jain

Alexandra Guarin

Journals

Future Oncology

Actions

Institutions

Pfizer (United States)

Oracle (United States)

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer patients in Brazil receiving palbociclib

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Cite this study

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Also consider